Market Price

117.20 

0.17 0.2%

as of Nov 12 '19

52 Week Range:

78.90 130.20


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in complementary areas, such as biodevices and genetics. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Oct '16 Oct '17 Dec '18
Equity (BVPS) 0.00
0.00
6.69
7.44
8.05
1.68
2.72
2.47
3.22
4.09
4.42
growth rate 11.2% 8.2% -79.1% 61.9% -9.2% 30.4% 27.0% 8.1%
Earnings BIT 0.00
-148.00
178.00
394.00
710.00
690.00
1,132.00
1,259.00
1,464.00
1,734.00
1,891.00
growth rate 100.0% 121.4% 80.2% -2.8% 64.1% 11.2% 16.3% 18.4% 9.1%
Avg.PE 0.00
0.00
32.47
39.47
62.48
37.86
38.89
32.55
growth rate 21.6% 58.3% -39.4% 2.7% -16.3%
ROA 0.00
-1.80
2.08
3.49
7.28
7.86
8.86
4.67
10.55
10.64
14.75
growth rate 100.0% 67.8% 108.6% 8.0% 12.7% -47.3% 125.9% 0.9% 38.6%
ROE 0.00
0.00
3.29
5.44
11.26
20.30
51.80
28.50
64.27
53.06
72.21
growth rate 65.4% 107.0% 80.3% 155.2% -45.0% 125.5% -17.4% 36.1%
ROIC 3.31
5.18
10.16
12.55
13.79
7.59
16.03
15.29
20.25
growth rate 56.5% 96.1% 23.5% 9.9% -45.0% 111.2% -4.6% 32.4%
Cur. Ratio 2.62
2.74
2.55
2.37
3.19
2.15
3.03
3.85
3.60
growth rate 4.6% -6.9% -7.1% 34.6% -32.6% 40.9% 27.1% -6.5%
Quick Ratio 1.03
1.13
1.08
1.24
1.71
1.17
1.47
2.34
2.24
growth rate 9.7% -4.4% 14.8% 37.9% -31.6% 25.6% 59.2% -4.3%
Leverage 1.58
1.54
1.56
6.98
5.04
7.41
5.14
4.85
4.93
growth rate -2.5% 1.3% 347.4% -27.8% 47.0% -30.6% -5.6% 1.7%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Oct '16 Oct '17 Dec '18
Acct.Receivable 0.00
0.00
773.00
967.00
1,001.00
1,235.00
980.00
937.00
913.00
998.00
1,036.00
growth rate 25.1% 3.5% 23.4% -20.7% -4.4% -2.6% 9.3% 3.8%
Acct.Payable 382.00
543.00
1,381.00
290.00
293.00
265.00
261.00
313.00
growth rate 42.2% 154.3% -79.0% 1.0% -9.6% -1.5% 19.9%
Cur.Assets 0.00
0.00
2,116.00
2,311.00
2,864.00
3,357.00
3,465.00
3,830.00
3,390.00
4,217.00
4,399.00
growth rate 9.2% 23.9% 17.2% 3.2% 10.5% -11.5% 24.4% 4.3%
Total Assets 2,993.00
5,598.00
5,284.00
5,711.00
6,262.00
6,558.00
6,588.00
7,913.00
7,649.00
8,586.00
10,777.00
growth rate 87.0% -5.6% 8.1% 9.7% 4.7% 0.5% 20.1% -3.3% 12.3% 25.5%
Cash 0.00
0.00
63.00
79.00
317.00
610.00
882.00
1,154.00
727.00
1,564.00
1,602.00
growth rate 25.4% 301.3% 92.4% 44.6% 30.8% -37.0% 115.1% 2.4%
Inventory 0.00
0.00
995.00
1,063.00
1,345.00
1,293.00
1,289.00
1,467.00
1,502.00
1,427.00
1,391.00
growth rate 6.8% 26.5% -3.9% -0.3% 13.8% 2.4% -5.0% -2.5%
Cur.Liabilities 0.00
0.00
808.00
843.00
1,123.00
1,415.00
1,086.00
1,781.00
1,117.00
1,094.00
1,223.00
growth rate 4.3% 33.2% 26.0% -23.3% 64.0% -37.3% -2.1% 11.8%
Liabilities 0.00
0.00
1,940.00
1,991.00
2,236.00
5,618.00
5,251.00
6,822.00
6,150.00
6,800.00
8,592.00
growth rate 2.6% 12.3% 151.3% -6.5% 29.9% -9.9% 10.6% 26.4%
LT Debt 0.00
728.00
673.00
697.00
668.00
3,691.00
3,624.00
4,463.00
4,468.00
4,953.00
6,443.00
growth rate -7.6% 3.6% -4.2% 452.5% -1.8% 23.2% 0.1% 10.9% 30.1%
Equity 0.00
0.00
3,344.00
3,720.00
4,026.00
940.00
1,311.00
1,068.00
1,487.00
1,770.00
2,185.00
growth rate 11.2% 8.2% -76.7% 39.5% -18.5% 39.2% 19.0% 23.5%
Common Shares 500.00
500.00
500.00
500.00
500.00
500.00
502.00
502.00
498.00
493.00
487.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.4% 0.0% -0.8% -1.0% -1.2%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Oct '16 Oct '17 Dec '18
Capital Expenditures 0.00
135.00
124.00
135.00
126.00
184.00
180.00
224.00
216.00
224.00
338.00
growth rate -8.2% 8.9% -6.7% 46.0% -2.2% 24.4% -3.6% 3.7% 50.9%
Cash Dividends 0.00
101.00
207.00
416.00
63.00
98.00
146.00
168.00
188.00
206.00
243.00
growth rate 105.0% 101.0% -84.9% 55.6% 49.0% 15.1% 11.9% 9.6% 18.0%
Cash From OA 0.00
98.00
254.00
497.00
454.00
681.00
626.00
664.00
713.00
1,346.00
1,790.00
growth rate 159.2% 95.7% -8.7% 50.0% -8.1% 6.1% 7.4% 88.8% 33.0%
FCF per Share 1.03
0.69
1.15
0.94
1.66
3.13
growth rate -33.0% 66.7% -18.3% 76.6% 88.6%
Sale Purchase of Stock 2.00
11.00
25.00
24.00
growth rate 450.0% 127.3% -4.0%
FCF 0.00
-37.00
130.00
362.00
328.00
497.00
431.00
440.00
497.00
1,122.00
1,452.00
growth rate 100.0% 178.5% -9.4% 51.5% -13.3% 2.1% 13.0% 125.8% 29.4%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Oct '16 Oct '17 Dec '18
Sales 2,825.00
2,760.00
3,582.00
4,233.00
4,336.00
4,561.00
4,785.00
4,765.00
4,888.00
5,307.00
5,825.00
growth rate -2.3% 29.8% 18.2% 2.4% 5.2% 4.9% -0.4% 2.6% 8.6% 9.8%
Op.Income 0.00
-125.00
85.00
245.00
436.00
504.00
1,132.00
1,259.00
1,464.00
1,734.00
1,891.00
growth rate 100.0% 188.2% 78.0% 15.6% 124.6% 11.2% 16.3% 18.4% 9.1%
IBT 0.00
-148.00
178.00
394.00
710.00
690.00
820.00
545.00
1,228.00
1,525.00
1,690.00
growth rate 100.0% 121.4% 80.2% -2.8% 18.8% -33.5% 125.3% 24.2% 10.8%
Net Income 0.00
-100.00
110.00
245.00
436.00
504.00
583.00
339.00
821.00
864.00
1,428.00
growth rate 100.0% 122.7% 78.0% 15.6% 15.7% -41.9% 142.2% 5.2% 65.3%
EPS 0.00
-0.20
0.22
0.49
0.87
1.01
1.16
0.68
1.65
1.75
2.93
growth rate 100.0% 122.7% 77.6% 16.1% 14.9% -41.4% 142.7% 6.1% 67.4%
Gross Profit 0.00
1,682.00
2,138.00
2,581.00
2,773.00
2,892.00
3,100.00
3,084.00
3,241.00
3,539.00
3,922.00
growth rate 27.1% 20.7% 7.4% 4.3% 7.2% -0.5% 5.1% 9.2% 10.8%
R&D 368.00
411.00
427.00
409.00
399.00
396.00
362.00
376.00
382.00
432.00
growth rate 11.7% 3.9% -4.2% -2.4% -0.8% -8.6% 3.9% 1.6% 13.1%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 486.00
500.00
442.00
430.00
529.00
growth rate 2.9% -11.6% -2.7% 23.0%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 973.00
929.00
1,036.00
970.00
994.00
growth rate -4.5% 11.5% -6.4% 2.5%
Acct.Payable 230.00
238.00
313.00
235.00
290.00
growth rate 3.5% 31.5% -24.9% 23.4%
Cur.Assets 4,239.00
4,076.00
4,399.00
4,379.00
4,484.00
growth rate -3.9% 7.9% -0.5% 2.4%
Total Assets 8,603.00
10,459.00
10,777.00
10,883.00
10,986.00
growth rate 21.6% 3.0% 1.0% 1.0%
Cash 1,558.00
1,286.00
1,602.00
1,728.00
1,755.00
growth rate -17.5% 24.6% 7.9% 1.6%
Inventory 1,420.00
1,441.00
1,391.00
1,361.00
1,404.00
growth rate 1.5% -3.5% -2.2% 3.2%
Cur.Liabilities 967.00
1,003.00
1,223.00
1,082.00
1,075.00
growth rate 3.7% 21.9% -11.5% -0.7%
Liabilities 6,621.00
8,341.00
8,592.00
8,566.00
8,575.00
growth rate 26.0% 3.0% -0.3% 0.1%
LT Debt 4,955.00
6,441.00
6,443.00
6,444.00
6,446.00
growth rate 30.0% 0.0% 0.0% 0.0%
Equity 1,970.00
2,118.00
2,185.00
2,317.00
2,411.00
growth rate 7.5% 3.2% 6.0% 4.1%
Common Shares 5.00
5.00
5.00
5.00
5.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 73.00
74.00
138.00
63.00
103.00
growth rate 1.4% 86.5% -54.4% 63.5%
Cash Dividends 60.00
61.00
60.00
79.00
78.00
growth rate 1.7% -1.6% 31.7% -1.3%
Cash From OA 267.00
550.00
584.00
389.00
318.00
growth rate 106.0% 6.2% -33.4% -18.3%
Sale Purchase of Stock 4.00
growth rate
FCF 194.00
476.00
446.00
326.00
215.00
growth rate 145.4% -6.3% -26.9% -34.1%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 1,415.00
1,480.00
1,564.00
1,455.00
1,547.00
growth rate 4.6% 5.7% -7.0% 6.3%
Op.Income 486.00
500.00
442.00
430.00
529.00
growth rate 2.9% -11.6% -2.7% 23.0%
IBT 437.00
418.00
418.00
381.00
455.00
growth rate -4.4% 0.0% -8.9% 19.4%
Net Income 384.00
347.00
345.00
312.00
371.00
growth rate -9.6% -0.6% -9.6% 18.9%
EPS
growth rate
Gross Profit 970.00
1,008.00
1,024.00
939.00
1,085.00
growth rate 3.9% 1.6% -8.3% 15.6%
R&D 102.00
108.00
125.00
102.00
111.00
growth rate 5.9% 15.7% -18.4% 8.8%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (80.76)

YOY Growth Grade:

C (61.51)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 38.81 38.81 29.30
EPS / Growth 19.9% 3.02 14.4%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 10.2%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.2% 14.8% 14.8%
Future PE 20.36 32.59 32.59
Future EPS 7.96 12.04 12.04
Value Price
MOS %
40.07
-65.8%
96.98
-17.3%
96.98
-17.3%
MOS Price 20.04 48.49 48.49
IRT 15.70 12.97 12.97

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.